LRRC8D Antibody - BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-46000
Key Product Details
Species Reactivity
Human, Mouse, Rat
Applications
ELISA, Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Format
BSA Free
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
leucine rich repeat containing 8 family, member D. (Uniprot# Q7L1W4)
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Description
Novus Biologicals Rabbit LRRC8D Antibody - BSA Free (NBP3-46000) is a polyclonal antibody validated for use in WB and ELISA. All Novus Biologicals antibodies are covered by our 100% guarantee.
Scientific Data Images for LRRC8D Antibody - BSA Free
Western Blot: LRRC8D Antibody - BSA Free [NBP3-46000] -
Western Blot: LRRC8D Antibody - BSA Free [NBP3-46000] - HEK-293 cells were subjected to SDS PAGE followed by western blot with (LRRC8D antibody) at dilution of 1:400Applications for LRRC8D Antibody - BSA Free
Application
Recommended Usage
Western Blot
1:500-1:2000
Application Notes
Theoretical Molecular Weight is 98-120 kDa
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
PBS, 50% Glycerol, pH (7.3)
Format
BSA Free
Preservative
0.02% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20C. Avoid freeze-thaw cycles.
Background: LRRC8D
Long Name
Volume-regulated anion channel subunit LRRC8D
Alternate Names
HsLRRC8D, LRRC5, UNQ213/PRO239
Gene Symbol
LRRC8D
Additional LRRC8D Products
Product Documents for LRRC8D Antibody - BSA Free
Product Specific Notices for LRRC8D Antibody - BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...